| 10.96 Data as of May 21 |  +0.28 / +2.62%Today’s Change | 9.52 Today|||52-Week Range 12.91 | -0.27% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $374.3M |
Company Description
AngioDynamics, Inc. provides innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. The company operates business through two segments: Vascular and Oncology/Surgery segment. The Vascular segment is responsible for products targeting the venous intervention, dialysis access, thrombus management and peripheral disease markets and has dedicated research & development and sales and marketing. The Oncology/Surgery segment is responsible for RF Ablation, embolization, Habib and NanoKnife product lines and has dedicated research & development and sales and marketing personnel. AngioDynamics was founded in 1988 by Eamonn P. Hobbs and is headquartered in Latham, NY.
Employees
Shareholders
| Individual stakeholders | 61.93% |
| Other institutional | 45.03% |
| Mutual fund holders | 23.94% |
Top Executives
| Joseph M. DeVivo | President, Chief Executive Officer & Director |
| George W. Bourne, MBA | SVP, Chief Technology & Operations Officer |
| Mark T. Frost | Chief Financial Officer & Executive Vice President |
| Donna Haire | SVP-Regulatory, Clinical & Medical Affairs |
| Louis J. Mazzarese | Chief Regulatory Officer & Senior Vice President |
.
